New quick MRI method for pediatric kidney disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates a new imaging technique called quick renal MRI, designed for children with congenital urinary tract anomalies who are at risk for kidney infections and scarring. The quick renal MRI aims to provide a rapid, injection-, sedation-, and radiation-free alternative to the current standard, the 99mTc-DMSA renal scan, which is time-consuming and involves radiation exposure. The study will compare the effectiveness of the quick renal MRI in detecting acute renal infections and scars against the DMSA scan. Participants will include children aged 0-21 years, with varying study durations depending on their enrollment aim.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Aim 1:

  * Patient is admitted to American Family Children's Hospital for a febrile UTI, suspected pyelonephritis, or diagnosed pyelonephritis
  * Undergoing clinical DMSA scan
* Aim 2:

  * Undergoing DMSA scans as a part of their routine clinical care
  * History of more than one UTI in the past year

Exclusion Criteria:

* Aim 1:

  * No evidence of pyuria on their urine analysis
  * Negative urine culture
  * Not comfortable with having a Quick MRI performed
* Both aims:

  * Contraindications to MRI

Where it's running

• American Family Children's Hospital
  Madison, Wisconsin, United States Recruiting

Study contacts

• Principal investigator: Shannon Cannon, MD — University of Wisconsin, Madison
• Study coordinator: Shannon Cannon, MD
• Email: cannon@urology.wisc.edu
• Phone: (608) 265-8574

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Diagnosing abdominal pain with a six-RNA blood test

  This study will test whether a blood test that measures six RNA markers can help doctors determine if abdominal pain in people aged 7 and older is caused by infections such as appendicitis, diverticulitis, or pyelonephritis.

  Recruiting True Bearing Diagnostics, Inc. · Washington D.C., District of Columbia · NCT07579312

• Temocillin pharmacokinetics in kids with febrile urinary tract infection

  This study tests how temocillin behaves in the bodies of children aged 0-15 with febrile UTIs due to Gram-negative bacteria who need hospitalization.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris, Ap-hp / DRCI · NCT07070102

• Comparing 7 days versus 14 days of antibiotics for kidney transplant patients with acute pyelonephritis

  This study is testing if kidney transplant patients with a certain type of kidney infection can be treated safely with just 7 days of antibiotics instead of the usual 14 days.

  Recruiting at 4 sites Phase 3 Assistance Publique - Hôpitaux de Paris · Bordeaux and 8 other locations · NCT05597540

• 3-day IV antibiotics versus 3-day IV followed by 7-day oral antibiotics for acute pyelonephritis in young children

  This project will test whether stopping after 3 days of IV antibiotics works as well as switching to 7 days of oral antibiotics for treating acute pyelonephritis in children under 3 years old with a first urinary infection.

  Recruiting at 3 sites Phase 4 Assistance Publique - Hôpitaux de Paris · Corbeil-Essonnes, Essonne and 14 other locations · NCT05544565

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.